AMERICAN ASSOCIATION FOR CANCER RESEARCH -- July 15th, 2015 -- Among women with a family history of breast cancer, those diagnosed with breast cancer gained weight at a greater rate compared with cancer-free women of the same age and menopausal status.
Journal in Which the Study was Published: Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research
Author: Kala Visvanathan, MD, MHS, associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health and director of the Clinical Cancer Genetics and Prevention Service at the Sidney Kimmel Comprehensive Cancer Center in Baltimore
Ad Statistics
Times Displayed: 22369
Times Visited: 452 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Background: Some previous studies have reported weight gain in cancer survivors; however, it was not clear whether survivors gained more weight compared with cancer-free women of similar age and menopausal status. The goal of the current study was to understand whether weight gain observed in breast cancer survivors was related to age or change in their menopausal status or if it was related to cancer treatment, Visvanathan explained.
How the Study Was Conducted: Visvanathan and colleagues recruited 303 breast cancer survivors and 307 age- and menopausal status-matched, cancer-free women from the Breast and Ovarian Surveillance Service cohort study, which comprises women with familial risk for breast and ovarian cancer, including BRCA1/2 mutation carriers. Eligible study participants were those who had completed a baseline questionnaire (the time point referred to as T1) and at least one follow-up questionnaire (administered every three or four years). Weight gain was computed using data from T1 and follow-up questionnaires.
Results: The researchers found that survivors who were diagnosed with breast cancer within five years before T1 had gained an average of 3.81 pounds more than cancer-free women. Survivors who were diagnosed with estrogen receptor-negative invasive cancer within five years before T1 had gained an average of 7.26 pounds more than cancer-free women. No significant weight gain was seen among those diagnosed with breast cancer more than five years before T1 or those treated with hormonal therapy for their estrogen receptor-positive cancer.
Survivors who had received chemotherapy (with or without hormonal therapy) within five years before T1 were more than twice as likely to have gained at least 11 pounds compared with cancer-free women. No significant weight gain was observed in those treated with chemotherapy more than five years before T1.
